Diabetes mellitus associated with clozapine therapy

Pharmacotherapy

Volumn 20, Issue 7 I, 2000, Pages 844-847

  Wehring, Heidi ^a   Alexander, Bruce ^a,b   Perry, Paul J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b Division of Cardiac Anesthesia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; EXTRAPYRAMIDAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; MALE; PATIENT MONITORING; SCHIZOPHRENIA;

EID: 0033932207     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.9.844.35201     Document Type: Article

References (22)

1. Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996;57(suppl 11):40-5.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105.
3. Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994;55(suppl B):47-52.
4. Koval MS, Rames LJ, Christie S. Diabetic ketoacidosis associated with clozapine therapy. Am J Psychiatry 1994;151:1520-1.
5. Kamran A, Doraiswamy PM, Jane JL, et al. Severe hyperglycemia associated with high doses of clozapine [letter]. Am J Psychiatry 1994;151:1395.
6. Peterson GA, Byrd SL. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996;153:737-8.
7. Kostakoglu AE, Yazici KM, Erbas T, et al. Ketoacidosis as a side-effect of clozapine: a case report. Acta Psychiatr Scand 1996;93:217-18.
8. Popli AP, Konicki PE, Jurgus GJ, et al. Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997;58:108-11.
9. Wirhing DA, Spellberg BJ, Erhart SM, et al. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998;44:778-83.
10. Colli A, Cocciolo M, Francobandiera F, Rogantin F, Cattalini N. Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care 1999;22:176-7.
11. Smith H, Kenney-Herbert J, Knowles L. Clozapine-induced diabetic ketoacidosis. Aust N Z J Psychiatry 1999;33(1):120-1.
12. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 1998;58:1355-62.
13. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio P. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73.
14. Hagg S, Joelsson L, Mjorndal T, et al. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998;59: 294-9.
15. Yazici KM, Erbas T, Yazici AH. The effect of clozapine on glucose metabolism. Exp Clin Endocrinol Diabetes 1998;106:475-7.
16. World Health Organization Study Group on Diabetes Mellitus. World Health Organization technical reports series 727. Geneva: World Health Organization, 1985.
17. 2 receptor agonists DOI and alpha-methyl 5HT on plasma glucose and insulin levels in the rat. Eur J Pharmacol 1990;1887:435-43.
18. Bustillo, JR, Buchanan RW, Irish D, et al. Differential effect of clozapine on weight: a controlled study. Am J Psychiatry 1996;153:817-19.
19. Colditz GA, Willett WC, Rotnilzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
20. James WPT. What are the health risks? The medical consequences of obesity and its health risks. Exp Clin Endocrinol Diabetes 1998;106(suppl 2):1-6.
21. Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 1995;374:542-6.
22. Allison DB, Mentore J, Moonseong H, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96.